Janina Frisch

Benefits of Recombinant Adeno-Associated Virus (rAAV)-Mediated Insulinlike Growth Factor I (IGF-I) Overexpression for the Long-Term Reconstruction of Human Osteoarthritic Cartilage by Modulation of the IGF-I Axis

Anja Weimer, Henning Madry, Jagadeesh K. Venkatesan et al. · Molecular Medicine · 2011 · 59 citations · Full text

Tumor-Specific Delivery of Immune Checkpoint Inhibitors by Engineered AAV Vectors

Johanna Reul, Janina Frisch, Christine E. Engeland et al. · Frontiers in Oncology · 2019 · 58 citations · Full text

PEO–PPO–PEO micelles as effective rAAV-mediated gene delivery systems to target human mesenchymal stem cells without altering their differentiation potency

Ana Rey‐Rico, Jagadeesh K. Venkatesan, Janina Frisch et al. · Acta Biomaterialia · 2015 · 53 citations

Regenerative Medicine, Cell-based Drug Delivery, Induced Pluripotent Stem Cell +11

DNA repair by MGMT, but not AAG, causes a threshold in alkylation-induced colorectal carcinogenesis

Jörg Fahrer, Janina Frisch, Georg Nagel et al. · Carcinogenesis · 2015 · 52 citations · Full text

Tumor Biology, Genome Instability, Dna Damage +13

Effective and durable genetic modification of human mesenchymal stem cells via controlled release of rAAV vectors from self-assembling peptide hydrogels with a maintained differentiation potency

Ana Rey‐Rico, Jagadeesh K. Venkatesan, Janina Frisch et al. · Acta Biomaterialia · 2015 · 50 citations

Tissue Engineering, Regenerative Medicine, Induced Pluripotent Stem Cell +9